Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01792050
Title Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors NewLink Genetics Corporation
Age Groups: adult
Covered Countries USA

No variant requirements are available.